Brief report: M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis

Arthritis and Rheumatism

Volumn 65, Issue 12, 2013, Pages 3045-3050

  Ammitzbøll, Christian G ^a   Thiel, Steffen ^b   Jensenius, Jens C ^b   Ellingsen, Torkell ^c   Hørslev Petersen, Kim ^d,e,f   Hetland, Merete L ^g,h   Junker, Peter ⁱ   Krogh, Niels S ^j   Østergaard, Mikkel ^k   Stengaard Pedersen, Kristian ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c SILKEBORG REGIONAL HOSPITAL   (Denmark)

^d King Christian the Xth Hospital   (Denmark)

^e King Christian 10th Hospital for Rheumatic Diseases South Jutland Hospital   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^j ZiteLab   (Denmark)

^k Mental Health Services CPH   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; FICOLIN; GLUCOCORTICOID; M FICOLIN; METHOTREXATE; PLACEBO; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; LECTIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLUOROMETRY; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; IMMUNOASSAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; ARTHRITIS, RHEUMATOID; BLOOD; DRUG COMBINATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LECTINS; MALE; METHOTREXATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84889074828     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38179     Document Type: Article

References (18)

1. Okroj M, Heinegard D, Holmdahl R, Blom AM,. Rheumatoid arthritis and the complement system. Ann Med 2007; 39: 517-30.
2. Thiel S, Gadjeva M,. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv Exp Med Biol 2009; 653: 58-73.
3. Teh C, Le Y, Lee SH, Lu J,. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 2000; 101: 225-32.
4. Kjaer TR, Hansen AG, Sorensen UB, Nielsen O, Thiel S, Jensenius JC,. Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol 2011; 90: 425-37.
5. Schlapbach LJ, Kjaer TR, Thiel S, Mattmann M, Nelle M, Wagner BP, et al. M-ficolin concentrations in cord blood are related to circulating phagocytes and to early-onset sepsis. Pediatr Res 2012; 71: 368-74.
6. Frankenberger M, Schwaeble W, Ziegler-Heitbrock L,. Expression of M-ficolin in human monocytes and macrophages. Mol Immunol 2008; 45: 1424-30.
7. Ammitzboll CG, Thiel S, Ellingsen T, Deleuran B, Jorgensen A, Jensenius JC, et al. Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis. Rheumatol Int 2011; 32: 1457-63.
8. Vander Cruyssen B, Nuytinck L, Boullart L, Elewaut D, Waegeman W, Van Thielen M, et al. Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1792-5.
9. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
10. Horslev-Petersen K, Hetland ML, Junker P, Podenphant J, Ellingsen T, Ahlquist P, et al, OPERA Study Group. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis 2013. E-pub ahead of print.
11. Van der Heijde DM,. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261-3]. J Rheumatol 1999; 26: 743-5.
12. Fries JF, Spitz P, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
13. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC,. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2010; 2: 167-80.
14. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A Simplified Disease Activity Index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244-57.
15. Wright HL, Moots RJ, Bucknall RC, Edwards SW,. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010; 49: 1618-31.
16. Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T,. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005; 209: 689-97.
17. Pincus T, Sokka T,. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am 2009; 35: 731-4,vi-vii.
18. Conaghan P,. Predicting outcomes in rheumatoid arthritis. Clin Rheumatol 2011; 30 Suppl 1: S41-7.